Table 2.

Selected ongoing trials of immunotherapy in SOTRs with skin cancers.

Study Design	Patient Population	Intervention	Results	NCT Number
Phase-I/II multi-institutional	Skin cancers with kidney transplant	Sirolimus + Prednisone + Ipilimumab and Nivolumab	No results available	NCT05896839
Phase IB/II multi-institutional [126]	Part A: kidney transplant Part B: any allogeneic transplant	RP1 intratumoral injection	Interim results from Part A: 27% ORR in 11 evaluable patients, 0 rejection	NCT04349436